Alnylam announces positive results from ILLUMINATE-B phase 3 pediatric study of lumasiran to treat hyperoxaluria type 1

Press/Media

Period24 Oct 2020

Media coverage

1

Media coverage

  • TitleAlnylam announces positive results from ILLUMINATE-B phase 3 pediatric study of lumasiran to treat hyperoxaluria type 1
    Media name/outletPharmaBiz
    Country/TerritoryIndia
    Date24/10/20
    PersonsJeffrey Saland
View all 1
View less